Chronic Pseudomonas Aeruginosa Infection clinical trials at UCSF

1 research study open to eligible people

Chronic Pseudomonas aeruginosa infection is a long-lasting lung infection caused by the bacterium Pseudomonas aeruginosa. UCSF is conducting a Phase 2b study of inhaled phage therapy called BX004. The trial enrolls people with cystic fibrosis and persistent Pseudomonas lung infection.

Showing trials for

  • Phage for CF Subjects With Pseudomonas Lung Infection

    open to eligible people ages 18 years and up

    The goal of this Phase 2b clinical trial is to see if nebulized phage (BX004) can treat chronic Pseudomonas aeruginosa (PsA) lung infection in CF subjects. The primary goal is to see if 8 weeks of twice daily BX004 can reduce the amount of PsA in the sputum compared to placebo (on top of background CF therapy).

    San Francisco, California and other locations

Last updated: